Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02822144Phase 3Completed
A Phase 3 trial of propofol, remifentanil, etomidate, succinylcholine, lidocaine in ischemic stroke, sponsored by CHU Rennes. Started Sep 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02822144.